EMEA (Europe, Middle East and Africa) Ipilimumab Market Report 2018

January 2018 | 106 pages | ID: E200E204948EN
QYResearch

Abstracts

In this report, the EMEA Ipilimumab market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Ipilimumab for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Ipilimumab market competition by top manufacturers/players, with Ipilimumab sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bristol-Myers Squibb

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Type I
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Drugs Store
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Ipilimumab Market Report 2017

1 IPILIMUMAB OVERVIEW

1.1 Product Overview and Scope of Ipilimumab
1.2 Classification of Ipilimumab
  1.2.1 EMEA Ipilimumab Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Ipilimumab Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3
  1.2.4
1.3 EMEA Ipilimumab Market by Application/End Users
  1.3.1 EMEA Ipilimumab Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Drugs Store
  1.3.4 Other
1.4 EMEA Ipilimumab Market by Region
  1.4.1 EMEA Ipilimumab Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Ipilimumab (2012-2022)
  1.5.1 EMEA Ipilimumab Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Ipilimumab Revenue and Growth Rate (2012-2022)

2 EMEA IPILIMUMAB COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Ipilimumab Market Competition by Players/Manufacturers
  2.1.1 EMEA Ipilimumab Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Ipilimumab Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Ipilimumab Sale Price by Players (2012-2017)
2.2 EMEA Ipilimumab (Volume and Value) by Type/Product Category
  2.2.1 EMEA Ipilimumab Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Ipilimumab Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Ipilimumab Sale Price by Type (2012-2017)
2.3 EMEA Ipilimumab (Volume) by Application
2.4 EMEA Ipilimumab (Volume and Value) by Region
  2.4.1 EMEA Ipilimumab Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Ipilimumab Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Ipilimumab Sales Price by Region (2012-2017)

3 EUROPE IPILIMUMAB (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Ipilimumab Sales and Value (2012-2017)
  3.1.1 Europe Ipilimumab Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Ipilimumab Revenue and Growth Rate (2012-2017)
3.2 Europe Ipilimumab Sales and Market Share by Type
3.3 Europe Ipilimumab Sales and Market Share by Application
3.4 Europe Ipilimumab Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Ipilimumab Sales Volume by Countries (2012-2017)
  3.4.2 Europe Ipilimumab Revenue by Countries (2012-2017)
  3.4.3 Germany Ipilimumab Sales and Growth Rate (2012-2017)
  3.4.4 France Ipilimumab Sales and Growth Rate (2012-2017)
  3.4.5 UK Ipilimumab Sales and Growth Rate (2012-2017)
  3.4.6 Russia Ipilimumab Sales and Growth Rate (2012-2017)
  3.4.7 Italy Ipilimumab Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Ipilimumab Sales and Growth Rate (2012-2017)

4 MIDDLE EAST IPILIMUMAB (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Ipilimumab Sales and Value (2012-2017)
  4.1.1 Middle East Ipilimumab Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Ipilimumab Revenue and Growth Rate (2012-2017)
4.2 Middle East Ipilimumab Sales and Market Share by Type
4.3 Middle East Ipilimumab Sales and Market Share by Application
4.4 Middle East Ipilimumab Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Ipilimumab Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Ipilimumab Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Ipilimumab Sales and Growth Rate (2012-2017)
  4.4.4 Israel Ipilimumab Sales and Growth Rate (2012-2017)
  4.4.5 UAE Ipilimumab Sales and Growth Rate (2012-2017)
  4.4.6 Iran Ipilimumab Sales and Growth Rate (2012-2017)

5 AFRICA IPILIMUMAB (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Ipilimumab Sales and Value (2012-2017)
  5.1.1 Africa Ipilimumab Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Ipilimumab Revenue and Growth Rate (2012-2017)
5.2 Africa Ipilimumab Sales and Market Share by Type
5.3 Africa Ipilimumab Sales and Market Share by Application
5.4 Africa Ipilimumab Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Ipilimumab Sales Volume by Countries (2012-2017)
  5.4.2 Africa Ipilimumab Revenue by Countries (2012-2017)
  5.4.3 South Africa Ipilimumab Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Ipilimumab Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Ipilimumab Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Ipilimumab Sales and Growth Rate (2012-2017)

6 EMEA IPILIMUMAB MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bristol-Myers Squibb
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ipilimumab Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bristol-Myers Squibb Ipilimumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview

7 IPILIMUMAB MANUFACTURING COST ANALYSIS

7.1 Ipilimumab Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ipilimumab

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ipilimumab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ipilimumab Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA IPILIMUMAB MARKET FORECAST (2017-2022)

11.1 EMEA Ipilimumab Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Ipilimumab Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Ipilimumab Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Ipilimumab Price and Trend Forecast (2017-2022)
11.2 EMEA Ipilimumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Ipilimumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Ipilimumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Ipilimumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Ipilimumab Sales Forecast by Type (2017-2022)
11.7 EMEA Ipilimumab Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ipilimumab
Figure EMEA Ipilimumab Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Ipilimumab Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure EMEA Ipilimumab Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Ipilimumab by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Drugs Store Examples
Table Key Downstream Customer in Drugs Store
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Ipilimumab Market Size (Million USD) by Region (2012-2022)
Figure Europe Ipilimumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Ipilimumab Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Ipilimumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Ipilimumab Revenue (Million USD) Status and Forecast by Countries
Figure Africa Ipilimumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Ipilimumab Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Ipilimumab Sales Volume and Growth Rate (2012-2022)
Figure EMEA Ipilimumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Ipilimumab Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Ipilimumab Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Ipilimumab Sales Share by Players (2012-2017)
Figure 2016 Ipilimumab Sales Share by Players
Figure 2017 Ipilimumab Sales Share by Players
Figure EMEA Ipilimumab Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Ipilimumab Revenue (Million USD) by Players (2012-2017)
Table EMEA Ipilimumab Revenue Share by Players (2012-2017)
Table 2016 EMEA Ipilimumab Revenue Share by Players
Table 2017 EMEA Ipilimumab Revenue Share by Players
Table EMEA Ipilimumab Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Ipilimumab Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Ipilimumab Sales Share by Type (2012-2017)
Figure Sales Market Share of Ipilimumab by Type (2012-2017)
Figure EMEA Ipilimumab Sales Market Share by Type (2012-2017)
Table EMEA Ipilimumab Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Ipilimumab Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ipilimumab by Type in 2016
Table EMEA Ipilimumab Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Ipilimumab Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Ipilimumab Sales Share by Application (2012-2017)
Figure Sales Market Share of Ipilimumab by Application (2012-2017)
Figure EMEA Ipilimumab Sales Market Share by Application in 2016
Table EMEA Ipilimumab Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Ipilimumab Sales Share by Region (2012-2017)
Figure Sales Market Share of Ipilimumab by Region (2012-2017)
Figure EMEA Ipilimumab Sales Market Share in 2016
Table EMEA Ipilimumab Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Ipilimumab Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Ipilimumab by Region (2012-2017)
Figure EMEA Ipilimumab Revenue Market Share Regions in 2016
Table EMEA Ipilimumab Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Ipilimumab Revenue and Growth Rate (2012-2017)
Table Europe Ipilimumab Sales (K Units) by Type (2012-2017)
Table Europe Ipilimumab Market Share by Type (2012-2017)
Figure Europe Ipilimumab Market Share by Type in 2016
Table Europe Ipilimumab Sales (K Units) by Application (2012-2017)
Table Europe Ipilimumab Market Share by Application (2012-2017)
Figure Europe Ipilimumab Market Share by Application in 2016
Table Europe Ipilimumab Sales (K Units) by Countries (2012-2017)
Table Europe Ipilimumab Sales Market Share by Countries (2012-2017)
Figure Europe Ipilimumab Sales Market Share by Countries (2012-2017)
Figure Europe Ipilimumab Sales Market Share by Countries in 2016
Table Europe Ipilimumab Revenue (Million USD) by Countries (2012-2017)
Table Europe Ipilimumab Revenue Market Share by Countries (2012-2017)
Figure Europe Ipilimumab Revenue Market Share by Countries (2012-2017)
Figure Europe Ipilimumab Revenue Market Share by Countries in 2016
Figure Germany Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure France Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure UK Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Ipilimumab Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Ipilimumab Sales (K Units) by Type (2012-2017)
Table Middle East Ipilimumab Market Share by Type (2012-2017)
Figure Middle East Ipilimumab Market Share by Type (2012-2017)
Table Middle East Ipilimumab Sales (K Units) by Applications (2012-2017)
Table Middle East Ipilimumab Market Share by Applications (2012-2017)
Figure Middle East Ipilimumab Sales Market Share by Application in 2016
Table Middle East Ipilimumab Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Ipilimumab Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Ipilimumab Sales Volume Market Share by Countries in 2016
Table Middle East Ipilimumab Revenue (Million USD) by Countries (2012-2017)
Table Middle East Ipilimumab Revenue Market Share by Countries (2012-2017)
Figure Middle East Ipilimumab Revenue Market Share by Countries (2012-2017)
Figure Middle East Ipilimumab Revenue Market Share by Countries in 2016
Figure Saudi Arabia Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Ipilimumab Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Ipilimumab Sales (K Units) by Type (2012-2017)
Table Africa Ipilimumab Sales Market Share by Type (2012-2017)
Figure Africa Ipilimumab Sales Market Share by Type (2012-2017)
Figure Africa Ipilimumab Sales Market Share by Type in 2016
Table Africa Ipilimumab Sales (K Units) by Application (2012-2017)
Table Africa Ipilimumab Sales Market Share by Application (2012-2017)
Figure Africa Ipilimumab Sales Market Share by Application (2012-2017)
Table Africa Ipilimumab Sales Volume (K Units) by Countries (2012-2017)
Table Africa Ipilimumab Sales Market Share by Countries (2012-2017)
Figure Africa Ipilimumab Sales Market Share by Countries (2012-2017)
Figure Africa Ipilimumab Sales Market Share by Countries in 2016
Table Africa Ipilimumab Revenue (Million USD) by Countries (2012-2017)
Table Africa Ipilimumab Revenue Market Share by Countries (2012-2017)
Figure Africa Ipilimumab Revenue Market Share by Countries (2012-2017)
Figure Africa Ipilimumab Revenue Market Share by Countries in 2016
Figure South Africa Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Table Bristol-Myers Squibb Ipilimumab Basic Information List
Table Bristol-Myers Squibb Ipilimumab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Ipilimumab Sales (K Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Ipilimumab Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Ipilimumab Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ipilimumab
Figure Manufacturing Process Analysis of Ipilimumab
Figure Ipilimumab Industrial Chain Analysis
Table Raw Materials Sources of Ipilimumab Major Manufacturers in 2016
Table Major Buyers of Ipilimumab
Table Distributors/Traders List
Figure EMEA Ipilimumab Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Ipilimumab Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Ipilimumab Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Ipilimumab Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Ipilimumab Sales Market Share Forecast by Region (2017-2022)
Table EMEA Ipilimumab Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Ipilimumab Revenue Market Share Forecast by Region (2017-2022)
Table Europe Ipilimumab Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Ipilimumab Sales Market Share Forecast by Countries (2017-2022)
Table Europe Ipilimumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Ipilimumab Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Ipilimumab Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Ipilimumab Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Ipilimumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Ipilimumab Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Ipilimumab Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Ipilimumab Sales Market Share Forecast by Countries (2017-2022)
Table Africa Ipilimumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Ipilimumab Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Ipilimumab Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Ipilimumab Sales Market Share Forecast by Type (2017-2022)
Table EMEA Ipilimumab Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Ipilimumab Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources